Unichem Laboratories Ltd. — Interim / Quarterly Report 2019

May 29, 2019

==> picture [595 x 9] intentionally omitted <==

==> picture [237 x 45] intentionally omitted <==

==> picture [6 x 454] intentionally omitted <==

May 29, 2019

The Corporate Relationship Dept. The Manager BSE Limited Listing Dept. 1 Floor, P. The National Stock Exchange of India Ltd. Rotunda Building Exchange Plaza, Floor, Street, Fort Bandra-Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051

Dear Sir,

Ref: BSE Scrip Code -506690: NSE Symbol -

==> picture [437 x 32] intentionally omitted <==

Dear

Pursuant to Regulation 47 of the Listing Regulations, please find enclosed copy of financial results of the Company for the quarter and year ended March 31, 2019 published in the following newspapers on May 25, 201 9.

Mumbai edition of Business Standard

==> picture [7 x 231] intentionally omitted <==

2. Mumbai edition of Sakal

Kindly take the same on your records.

Thanking you, LABORATORIES LIMITED

==> picture [135 x 32] intentionally omitted <==

Thakore Head- Legal Company Secretary Encl:

==> picture [193 x 23] intentionally omitted <==

Registered Unichem Bhavan, Prabhat Estate, Off S. V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. Tel.: 66888333 Fax.: 26784391 www.unichemlabs.com

M MAY

==> picture [42 x 13] intentionally omitted <==

==> picture [10 x 7] intentionally omitted <==

==> picture [6 x 6] intentionally omitted <==

==> picture [7 x 11] intentionally omitted <==

==> picture [7 x 11] intentionally omitted <==

==> picture [21 x 11] intentionally omitted <==

==> picture [7 x 11] intentionally omitted <==

==> picture [19 x 10] intentionally omitted <==

==> picture [10 x 6] intentionally omitted <==

==> picture [8 x 16] intentionally omitted <==

==> picture [14 x 14] intentionally omitted <==

==> picture [39 x 11] intentionally omitted <==

==> picture [458 x 12] intentionally omitted <==

==> picture [495 x 6] intentionally omitted <==

==> picture [495 x 43] intentionally omitted <==

==> picture [64 x 37] intentionally omitted <==

CIN 2451

I

Office: Unichem Bhavan, Prabhat Estate, Off S.V. Road, Jogeshwari (West), Mumbai 400 102 . . No.: 91 (22) 6688 8333 Fax. No.: 91 (22) 2678 4391

www.unichemlabs.com E-mail ID.: shares8unichemlabs.com

==> picture [495 x 39] intentionally omitted <==

==> picture [446 x 10] intentionally omitted <==

==> picture [48 x 192] intentionally omitted <==

Particulars

==> picture [16 x 9] intentionally omitted <==

==> picture [261 x 10] intentionally omitted <==

==> picture [63 x 19] intentionally omitted <==

==> picture [334 x 19] intentionally omitted <==

==> picture [446 x 73] intentionally omitted <==

==> picture [19 x 10] intentionally omitted <==

(loss) for the period from discontinued operations Total Comprehensive Income for the period [Comprising of for the period (after tax) and other comprehensive income (after tax)] Paid-up Equity Share Capital Other Equity [Reserves excluding Revaluation Reserve] Earnings per share (of each) from continuing operations and discontinued operations (in

==> picture [260 x 10] intentionally omitted <==

==> picture [17 x 10] intentionally omitted <==

==> picture [260 x 10] intentionally omitted <==

==> picture [18 x 19] intentionally omitted <==

==> picture [260 x 19] intentionally omitted <==

==> picture [18 x 19] intentionally omitted <==

==> picture [260 x 19] intentionally omitted <==

==> picture [19 x 19] intentionally omitted <==

==> picture [259 x 19] intentionally omitted <==

==> picture [446 x 32] intentionally omitted <==

==> picture [34 x 68] intentionally omitted <==

==> picture [9 x 67] intentionally omitted <==

==> picture [23 x 5] intentionally omitted <==

==> picture [191 x 6] intentionally omitted <==

==> picture [11 x 64] intentionally omitted <==

1 The standalone financial results for the quarter and year ended March, 2019 and consolidated financial results for the year ended March 2019 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on 24th May, 201 9. The statutory auditors have expressed an unqualified audit opinion on these standalone and consolidated financial results. The above is an extract of the detailed format of the standalone and consolidated financial results filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of these standalone and consolidated financial results are available on the of the Stock Exchanges www.bseindia.com and www.nseindia.com and Company at www.unichemlabs.com.

==> picture [33 x 101] intentionally omitted <==

amounting to 321,731.05 lakhs had been recognised and disclosed under discontinued operations in the above results.

==> picture [11 x 28] intentionally omitted <==

3 The Board recommends a final dividend of 41- per share (200 %) (face value of per share) for the year ended March, 2019. The payment is subject to the approval of the shareholders in the ensuing Annual General Meeting of the Company.

==> picture [495 x 8] intentionally omitted <==

==> picture [495 x 54] intentionally omitted <==

----- Start of picture text -----

For Laboratories
----- End of picture text -----

==> picture [600 x 845] intentionally omitted <==

----- Start of picture text -----

CIN
Office: Unichem Bhavan, Prabhat Estate, Off S.V. Road, (West), Mumbai - 400 102
Tel. No.: 91 (22) 6688 8333 Fax. No.: 91 (22) 2678 4391
www.unichemlabs.com E-mail ID.: sharesQunichemlabs.com
P a r t i c u l a r s Quarter Quarter Year Year Year
ended ended ended ended ended ended
1 Total income (excluding other income) from continuing
operations
2 Profit (loss) before tax from continuing operations
3 Profit (loss) before tax from discontinued operations
(Refer note 2)
4 Profit (loss) for the period from continuing operations
after ,
5 (loss) for the period from discontinued operations
after
6 Total Comprehensive Income for the period
[Comprising of for the period (after tax) and
other comprehensive income (after tax)]
7 Capital
8 Other [Reserves excluding Revaluation Reserve]
9 Eamings per share (of each) from
operations and discontinued operations (in
(a) Basic
Diluted
Motes:
1 The standalone financial results for the quarter and year ended March, 201 9 and consolidated financial results for year ended 31 st
March 2019 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on
24th May, 201 9. The statutory auditors have expressed an unqualified audit opinion on these standalone and consolidated financial results.
The above is an extract of the detailed format of the standalone and consolidated financial results filed with the Stock Exchanges under
Regulation 33 of the (Listing Obligations and Disclosure Requirements) Regulations', 2015. The full format of these and
consolidated financial results are available on the of the Stock Exchanges and www.ns&india.com and
Company at ,
2 During the year ended 31st March 2018, based on the approval obtained from the the Company had transferred its business
of manufacture, sale, and distribution of domestic formulations in lndia and ("ldentified Business") by way of slump sale
on going concern basis to Torrent Pharmaceuticals Limited ("Torrent"). ldentified business includes portfolio of several brands in lndia and
Nepal, manufacturing facility at and employees performing work in relation to said business. Gain on sale of ldentified Business (net)
amounting to 321,731.05 had been recognised and disclosed under discontinued in the above results.
3 Board recommends a final dividend of per share (200 %) (face value of per for the year ended 31 st March, 2019.
payment is subject to the approval of the shareholders in the ensuing Annual General Meeting of Company.
By Order of Board
For Laboratories
S
A.
Place: Mumbai Chairman Managing Director
Dale: 24th May, DIN: 00001 285
----- End of picture text -----